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INTRODUCTION                                                    
Despite technological and conceptual de-
velopments in the practice of medicine, the 
formation and growth of renal calculi contin-
ue to afflict mankind. The incidence of kid-
ney stones has increased in western societies 
in the last five decades, in association with 
economic development. Most calculi in the 
urinary system arise from a common compo-
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ABSTRACT
Objective: The aim of the present study was to investigate the effect of juice extract and alcohol 
extract of fruit of Pyracantha crenulata (D.Don) Roem (Rosaceae) against ethylene glycol-
induced urolithiasis in male albino rats. 
Patients and Methods: Lithiasis was induced in rats by administering 0.75% ethylene glycol 
in drinking water for 28 days and was manifested by hyperoxaluria as well as increased renal 
excretion of calcium, phosphate and a low urinary magnesium content. Curative and preventive 
treatment was then tried by supplementation with juice and alcohol extracts (250 mg/kg b.w., p.o.) 
of P. crenulata fruit.
Results: The increased deposition of stone forming constituents in the kidneys of calculogenic rats 
was significantly lowered by curative and preventive treatment using juice and alcohol extracts 
(250 mg/kg b.w., p.o.) of P. crenulata fruit which showed a regulatory action on endogenous 
oxalate synthesis.
Conclusion: From this study, we conclude that both prophylactic and therapeutic treatment with 
juice and alcohol extract of fruit of P. crenulata may reduce precipitation of calcium oxalate, with 
improvement of kidney function as well as cytoprotective effect 
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nent of urine, calcium oxalate (CaOx), repre-
senting up to 80% of all analyzed stones1.
A large number of plant drugs have been 
used in India since ancient times which claim 
efficient cure of urinary stones2. Amongst 
the medicinal plants used in the treatment of 
urolithiasis are ‘patharphor’ (Didymocarpus 
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PATIENTS AND METHODS                                  
Fresh Pyracantha crenulata fruit were 
collected from local areas of Dehradun, 
Uttarakhand, India during May 2008 and 
authenticated at the Botanical Survey of India 
(BSI), Dehradun, India. A voucher specimen 
of the plant was deposited in the Botanical 
Survey of India herbarium under the number 
BSD 112215 for further reference.
The fresh and semi-ripe fruit were cut into 
small pieces and fed through a juicer. The 
juice was filtered and vacuum dried to obtain 
P. crenulata fruit juice extract (PCJE, yield 
17% w/w). In addition, the fruit were sliced 
using a home slicer, then shade-dried, pulve-
rized and passed through a 20-mesh sieve. 
The dried, coarsely powdered plant material 
was extracted with 70% (v/v) alcohol by the 
hot continuous    extraction  method   using a 
soxhlet   apparatus  at  a temperature of 60- 
70ºC. The solvent was evaporated under va-
cuum yielding a semisolid mass (PCAE, yield 
22% w/w with respect to the dried powder). 
Both extracts were stored in tight containers 
in a desiccator for further use16.
For acute toxicity studies, albino rats of 
either sex weighing 150-200 g were selected, 
and healthy adult male albino rats weighing 
150-200 g were selected for assessing the 
antiurolithogenic activity. The animals 
were acclimatized to  standard  laboratory 
conditions (temperature: 25 ± 2ºC) and 
maintained on a 12-h light: 12-h dark cycle. 
They were housed in  polypropylene cages 
and provided with regular rat chow (Lipton 
India Ltd., Mumbai, India) and drinking water 
ad libitum. The animal care and experimental 
protocols were approved by the Institutional 
Animal Ethical Committee (IAEC).
The acute oral toxicity study17 was 
carried out as per the guidelines set by the 
Organization for Economic Co-Operation 
and Development (OECD) received from 
the Committee for the Purpose of Control 
and Supervision of Experiments on Animals 
pedicellata), several Bergenia species, three 
species of Tribulus (T. systoides, T. terrestris 
and T. alatus), ‘manjit’ (Rubia cordifolia and 
Rubia tinctorum), ‘varuna’ (Crataeva nurva-
la) and ‘imli’ (Tamarindus indica)3, Costus 
spiralis4, Raphanus sativus5, Moringa oleif-
era6, Crataeva adansonii7, Melia azedarach8 
and Eleusine coracana9.
“The plant Pyracantha crenulata Roem, 
syn. Crataegus crenulata Roxb (Rosaceae), 
locally known as Ghingaaru, is found in the 
Himalayas from Sutlaj to Bhutan, at altitudes 
of 800-2500 m.  In Ayurvedic medicine it 
is reported to be useful in the treatment of 
a number of ailments, including hepatic, 
stomach and skin diseases due to its diuretic, 
depurative, tonic, antirheumatic, cardiotonic, 
hypoglycemic, hypotensive, anti-inflamma-
tory and lithontripic properties10-14. However, 
there are no records of systematic pharmaco-
logical studies that support its antiurolitho-
genic effect. Due to the wide distribution in 
Uttarakhand, India, and in continuation of our 
research work on P. crenulata15, the present 
investigation was carried out to determinate 
the antiurolithogenic property of the alcohol 
and juice extracts of the fruit of P. crenulata 
using an ethylene glycol induced hyperox-
aluria model in albino rats and to confirm the 
traditional medicinal use of the plant.
Fig. 1:  Fruits and leaves of P. crenulata
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(CPCSEA). One tenth of the median lethal 
dose (LD50) was taken as an effective dose18. 
From the acute toxicity study, the LD50 
cut-off dose was found to be 2500 mg/kg 
body weight for both extracts. Hence, the 
therapeutic dose was taken as 250 mg/kg 
body weight for both extracts.
An ethylene glycol induced 
hyperoxaluria model19  was used to assess 
the antiurolithogenic activity in albino rats. 
The animals were divided into seven groups 
containing six animals each. 
Group N served as a normal control • 
group and received regular rat food 
and drinking water ad libitum. 
Groups PR, PR I and PR II for the • 
preventive regimen
Groups CR, CR I and CR II for the • 
curative regimen
Starting from day 1, ethylene glycol 
(0.75% v/v) in the drinking water was given 
to all groups except the control group for the 
induction of renal calculi. 
From day 1 - 28, group PR I received 
alcohol extract (250 mg/kg body weight) 
and group PR II juice extract (250 mg/kg 
body weight). Group PR did not receive any 
extract.
From day 15 – 28, group CR received a 
standard antiurolithogenic drug (cystone; 750 
mg/kg body weight20-23), while groups CR I 
and CR II received alcohol extract (250 mg/
kg body weight) and juice extract (250 mg/kg 
body weight), respectively.
All extracts were given orally once daily. 
All animals were kept in individual metabolic 
cages, and 24-h urine samples were collected 
on day 28. The animals had free access to 
drinking water during the urine collection 
period. A drop of concentrated hydrochloric 
acid was added to the urine before it was 
stored at 4ºC. The urine was analyzed for 
calcium24, phosphate25 and oxalate26.
After the experimental period, blood was 
collected from the retro-orbital area under 




Normal (N) Vehicle 0.28 ± 0.01 1.18 ± 0.03 2.96 ± 0.04
Calculi induced (PR) Vehicle 2.61 ± 0.17* 3.85 ± 0.18* 6.82 ± 0.13*
Cystone treated (CR) 750 0.46 ± 0.10*** 1.34 ± 0.10*** 3.36 ± 0.03***
Alcohol extract (CR I) 250 0.86 ± 0.01*** 2.03 ± 0.24*** 3.40 ± 0.26***
Juice extract (CR II) 250 2.25 ± 0.24** 3.52 ± 0.31** 5.98 ± 0.28**
Alcohol extract (PR I) 250 1.28 ± 0.13*** 2.27 ± 0.13*** 4.52 ± 0.22***
Juice extract (PR II) 250 2.36 ± 0.16** 3.41 ± 0.23** 6.48 ± 0.32**
Values are expressed as mean ± SEM of 6 observations; Statistical comparisons are made between Group N vs Group PR and CR 
(*P<0.001); Group PR vs PR I and PR II (**P<0.01); Group CR vs Group CR I and CR II (***P<0.01)
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anesthetic conditions, and the animals were 
sacrificed by cervical decapitation. The serum 
was separated by centrifugation at 10,000 
rpm for 10 min and analyzed for creatinine, 
urea nitrogen27 and uric acid28.
The abdomen was cut open to remove 
both kidneys, which  were dissected from 
extraneous tissue and preserved in 10% 
neutral formalin. They were then dried 
at 80ºC in a hot-air oven. A sample of 100 
mg of the dried kidney was boiled in 10 
ml of 1N hydrochloric acid for 30 min 
and homogenized. The homogenate was 
centrifuged at 2,000 rpm for 10 min and the 
supernatant was separated29. The calcium24, 
phosphate25 and oxalate26 contents in the 
kidney homogenate were determined.
The results  were expressed as mean ± SD. 
Differences  among the  data were statistically 
analyzed using one-way  ANOVA followed 
by Student Newman Keul’s test (GraphPad 
Prism software for Windows, Version 
5.01.2007). Statistical significance was set 
accordingly30.
RESULTS                                                            
In the  present  study, chronic 
administration of 0.75% (v/v)  ethylene 
glycol aqueous solution to male albino rats 
resulted in hyperoxaluria. Oxalate, calcium 
and phosphate excretion were grossly 
increased in calculi-induced animals (Table 
1). However, supplementation with juice 
and alcohol extracts of P. crenulata fruit 
significantly (p<0.001) lowered the elevated 
levels of oxalate, calcium and phosphate in 
urine and kidney in the animals of groups CR 
I and CR II (curative regimen) and those of 
groups PR I and PR II (preventive regimen) 
as compared to group PR (calculi-induced) 
(Table 1).
The deposition of crystalline components 
in the renal tissues, namely oxalate, phosphate 
and calcium, was increased in the stone-for-
ming rats (Table 2). Treatment with juice and 
alcohol extracts of P. crenulata fruit signifi-
cantly (p<0.001) reduced the renal content of 
these stone-forming constituents in both regi-
mens (Table 2, CR I, CR II, PR I, PR II). 
Table 2: Kidney retention of stone forming constituents in control and experimental animals
Values are expressed as mean ± SEM of 6 observations; Statistical comparisons are made between Group N vs Group PR and CR 




Normal (N) Vehicle 1.36 ± 0.02 3.02 ± 0.03 2.58 ± 0.04
Calculi induced (PR) Vehicle 4.85 ± 0.11* 4.94 ± 0.21* 3.88 ± 0.11*
Cystone treated (CR) 750 2.15 ± 0.03*** 1.82 ± 0.27*** 1.62 ± 0.03***
Alcohol extract (CR I) 250 2.18 ± 0.03*** 2.82 ± 0.21*** 1.80 ± 0.06***
Juice extract (CR II) 250 3.42 ± 0.06** 4.26 ± 0.34** 3.47 ± 0.16**
Alcohol extract (PR I) 250 4.28 ± 0.36*** 3.46 ± 0.22*** 3.02 ± 0.07***
Juice extract (PR II) 250 4.11 ± 0.23** 4.49 ± 0.32** 3.50 ± 0.16**
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Although the extent of reduction was in-
significant on inter-regimen comparison 
(curative versus preventive regimens), the 
differences were significant (p<0.001) when 
compared with the cystone-treated animals 
(Table 2).
Serum uric acid and blood urea nitrogen 
(BUN) were remarkably increased in the 
stone-forming animals (Table 3), while se-
rum creatinine was only slightly elevated in 
group PR indicating marked renal damage. 
However, P. crenulata extracts significantly 
(p<0.001) lowered the elevated serum le-
vels of creatinine, uric acid and BUN in the 
groups of curative and preventive regimen 
(Table 3). 
DISCUSSION                                                        
In the present study, male rats were 
selected to induce urolithiasis because the 
urinary system of male rats resembles that of 
humans and earlier studies showed that the 
amount of stone deposition in female rats was 
significantly less31,32.
Urinary supersaturation with stone-
forming constituents is generally considered 
one of the causative factors in calculogenesis. 
Previous studies indicate that in response to 
the administration of ethylene glycol (0.75%, 
v/v) over a 14-day period, young male albino 
rats form renal calculi composed mainly 
of calcium oxalate18,33,34. The biochemical 
mechanisms of this process are related to 
an increase in the urinary concentration of 
oxalate. Stone formation in ethylene glycol-
fed animals is caused by hyperoxaluria, 
which causes increased urinary retention and 
excretion of oxalate33. Similar results have 
been obtained when rats were treated with 
ethylene glycol and ammonium oxalate35,36.
In the present study, oxalate and calcium 
excretion progressively increased in stone-
forming animals (PR). Since it is accepted 
that hyperoxaluria is a more significant risk 
Table 3: Serum parameters in control and experimental animals
Values are expressed as mean ± SEM of 6 observations; Statistical comparisons are made between Group N vs Group PR and CR 
(*P<0.001); Group PR vs PR I and PR II (**P<0.01); Group CR vs Group CR I and CR II (***P<0.01)
Groups Dose (mg/kg)
Serum parameters (mg/dl)
BUN Creatinine Uric acid
Normal (N) Vehicle 38.21 ± 0.16 0.56 ± 0.03 1.26 ± 0.04
Calculi induced (PR) Vehicle 52.67 ± 0.46* 0.98 ± 0.08* 3.48 ± 0.11*
Cystone treated (CR) 750 42.60 ± 0.38*** 0.58 ± 0.01*** 1.88 ± 0.03***
Alcohol extract (CR I) 250 40.31 ± 0.22*** 0.60 ± 0.03*** 2.06 ± 0.04***
Juice extract (CR II) 250 52.90 ± 0.42** 0.78 ± 0.07** 3.18 ± 0.08**
Alcohol extract (PR I) 250 46.23 ± 0.23*** 0.61 ± 0.06*** 2.46 ± 0.06***
Juice extract (PR II) 250 51.87 ± 0.36** 0.84 ± 0.10** 3.12 ± 0.16**
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factor in the pathogenesis of renal stones 
than hypercalciuria, the changes in urinary 
oxalate levels are relatively more important 
than those of calcium37,38. Increased urinary 
calcium is a factor favoring the nucleation 
and precipitation of calcium oxalate or 
apatite (calcium phosphate) from urine 
and subsequent crystal growth39. However, 
juice and alcohol extracts of P. crenulata 
fruit lowered the levels of oxalate as well as 
calcium excretion.
An increase in urinary phosphate is 
observed in stone-forming rats (PR). 
Increased urinary phosphate excretion along 
with oxalate stress seems to provide an 
environment appropriate for stone formation 
by forming calcium phosphate crystals, 
which epitaxially induces calcium oxalate 
deposition40. Treatment with P. crenulata 
fruit extract restored the phosphate level, thus 
reducing the risk of stone formation.
In urolithiasis, the glomerular filtration 
rate (GFR) decreases due to obstruction of 
urine outflow by stones in the urinary system. 
Due to this, the waste products, particularly 
nitrogenous substances such as urea, 
creatinine, and uric acid accumulate in the 
blood41. Also, increased lipid peroxidation 
and decreased levels of antioxidant potential 
have been reported in the kidneys of rats 
supplemented with a calculi-producing 
diet42,43. In this context, oxalate has been 
reported to induce lipid peroxidation and 
to cause renal tissue damage by reacting 
with polyunsaturated fatty acids in the cell 
membrane44. In the stone-forming rats (PR) 
marked renal damage was seen by the elevated 
serum levels of creatinine, uric acid and 
BUN. However, curative and prophylactic 
treatment with juice and alcohol extracts of P. 
crenulata fruit caused diuresis15 and hastened 
the process of dissolving the preformed 
stones and preventing new stone formation in 
the urinary system.
In conclusion, the presented data indicate 
that administration of juice and alcohol 
extracts of P. crenulata fruit to rats with 
ethylene glycol-induced lithiasis reduced 
and prevented the growth of urinary 
stones, thus supporting folk information 
regarding the antiurolithogenic activity of 
the plant. The mechanism underlying this 
effect is still unknown, but is apparently 
related to increased diuresis and lowering 
of urinary concentrations of stone forming 
constituents. These effects could explain the 
antiurolithogenic property of P. crenulata.
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